ConceptMap-immunization-covid-mapping-cvx-air

Sourcecards.smarthealth.terminology#current:SMART Health Cards: Terminology (v4.0.1)
resourceTypeConceptMap
idimmunization-covid-mapping-cvx-air
canonicalhttps://github.com/dvci/shc-terminology/ConceptMap/covid-mapping-cvx-air
version2022.1
statusdraft
publisherVCI
nameImmunizationCovidCVXAirConceptMap
titleMapping between CVX and AIR Covid Codes
date2021-09-22
descriptionA Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction
copyrightCreative Commons 0
jurisdictionsau
sourceshttps://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222 http://hl7.org/fhir/sid/cvx
targetshttp://hl7.org/fhir/sid/cvx https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats|20210222
Usages(none)

Mapping from (not specified) to (not specified)

DRAFT. Published on 2021-09-22 by VCI (VCI: https://vci.org ). Creative Commons 0

A Mapping between CVX and AIR Codes for Covid vaccinations. This mapping is bi-directional - one group for each direction


Group 1 Mapping from Australian Immunisation Register Vaccine (version 20210222) to CVX - US Vaccine Codes

Source Code Relationship Target Code
COVAST (COVID-19 Vaccine AstraZeneca) is equivalent to 210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL)
COMIRN (Pfizer Comirnaty) is equivalent to 208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose)
MODERN (Moderna Spikevax) is equivalent to 207 (COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose)

Group 2 Mapping from CVX - US Vaccine Codes to Australian Immunisation Register Vaccine (version 20210222)

Source Code Relationship Target Code
210 (COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL) is equivalent to COVAST (COVID-19 Vaccine AstraZeneca)
208 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose) is equivalent to COMIRN (Pfizer Comirnaty)
207 (COVID-19, mRNA, LNP-S, PF, 100 mcg or 50 mcg dose) is equivalent to MODERN (Moderna Spikevax)
211 (COVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL) (not mapped)
212 (COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL) (not mapped)
213 (SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED) (not mapped)
217 (COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose) (not mapped)
218 (COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose) (not mapped)
219 (COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose) (not mapped)
500 (COVID-19 Non-US Vaccine, Product Unknown) (not mapped)
501 (COVID-19 IV Non-US Vaccine (QAZCOVID-IN)) (not mapped)
502 (COVID-19 IV Non-US Vaccine (COVAXIN)) (not mapped)
503 (COVID-19 LAV Non-US Vaccine (COVIVAC)) (not mapped)
504 (COVID-19 VVnr Non-US Vaccine (Sputnik Light)) (not mapped)
505 (COVID-19 VVnr Non-US Vaccine (Sputnik V)) (not mapped)
506 (COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology)) (not mapped)
507 (COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)) (not mapped)
508 (COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)) (not mapped)
509 (COVID-19 PS Non-US Vaccine (EpiVacCorona)) (not mapped)
510 (COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)) (not mapped)
511 (COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)) (not mapped)

Produced 08 Sep 2023